These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38892381)

  • 41. Caspase-1-mediated regulation of fibrogenesis in diet-induced steatohepatitis.
    Dixon LJ; Berk M; Thapaliya S; Papouchado BG; Feldstein AE
    Lab Invest; 2012 May; 92(5):713-23. PubMed ID: 22411067
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polaprezinc attenuates liver fibrosis in a mouse model of non-alcoholic steatohepatitis.
    Sugino H; Kumagai N; Watanabe S; Toda K; Takeuchi O; Tsunematsu S; Morinaga S; Tsuchimoto K
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1909-16. PubMed ID: 18422963
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
    Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Time-restricted feeding has a limited effect on hepatic lipid accumulation, inflammation and fibrosis in a choline-deficient high-fat diet-induced murine NASH model.
    Sato T; Oishi K
    PLoS One; 2024; 19(1):e0296950. PubMed ID: 38285666
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mouse models of diet-induced nonalcoholic steatohepatitis reproduce the heterogeneity of the human disease.
    Machado MV; Michelotti GA; Xie G; Almeida Pereira T; Boursier J; Bohnic B; Guy CD; Diehl AM
    PLoS One; 2015; 10(5):e0127991. PubMed ID: 26017539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Suppression of STK39 weakens the MASLD/MASH process by protecting the intestinal barrier.
    Xu Q; Liu F; Wu Z; Chen M; Zhou Y; Shi Y
    Biosci Trends; 2024 Jul; 18(3):289-302. PubMed ID: 38925962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The adiponectin-derived peptide ALY688 protects against the development of metabolic dysfunction-associated steatohepatitis.
    Huang Z; Sung HK; Yan X; He S; Jin L; Wang Q; Wu X; Hsu HH; Pignalosa A; Crawford K; Sweeney G; Xu A
    Clin Transl Sci; 2024 Jun; 17(6):e13760. PubMed ID: 38847320
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of Caffeine and Chlorogenic Acid on Nonalcoholic Steatohepatitis in Mice Induced by Choline-Deficient, L-Amino Acid-Defined, High-Fat Diet.
    Dungubat E; Watabe S; Togashi-Kumagai A; Watanabe M; Kobayashi Y; Harada N; Yamaji R; Fukusato T; Lodon G; Sevjid B; Takahashi Y
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33353230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model.
    Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction.
    Li S; Li X; Chen F; Liu M; Ning L; Yan Y; Zhang S; Huang S; Tu C
    J Nutr Biochem; 2022 Feb; 100():108888. PubMed ID: 34695558
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic alterations in the gut microbiota and metabolome during the development of methionine-choline-deficient diet-induced nonalcoholic steatohepatitis.
    Ye JZ; Li YT; Wu WR; Shi D; Fang DQ; Yang LY; Bian XY; Wu JJ; Wang Q; Jiang XW; Peng CG; Ye WC; Xia PC; Li LJ
    World J Gastroenterol; 2018 Jun; 24(23):2468-2481. PubMed ID: 29930468
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetic Ablation of STE20-Type Kinase MST4 Does Not Alleviate Diet-Induced MASLD Susceptibility in Mice.
    Caputo M; Andersson E; Xia Y; Hou W; Cansby E; Erikson M; Lind DE; Hallberg B; Amrutkar M; Mahlapuu M
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38397122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Histological evaluation of nintedanib in non-alcoholic steatohepatitis mice.
    Susutlertpanya W; Wakuda H; Otani N; Kuramoto T; Li L; Kuranari M; Sekiguchi A; Kudo H; Uchida T; Imai H; Uemura N
    Life Sci; 2019 Jul; 228():251-257. PubMed ID: 31078545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mechanism of hepatocyte regeneration inhibition in rats with liver fibrosis induced by lipogenic methionine-choline- deficient diet].
    Mu YP; Xi XH; Chen XR
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(48):3430-6. PubMed ID: 20223120
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis.
    Rivera CA; Gaskin L; Allman M; Pang J; Brady K; Adegboyega P; Pruitt K
    BMC Gastroenterol; 2010 May; 10():52. PubMed ID: 20509914
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fibroblast growth factor 21 limits lipotoxicity by promoting hepatic fatty acid activation in mice on methionine and choline-deficient diets.
    Fisher FM; Chui PC; Nasser IA; Popov Y; Cunniff JC; Lundasen T; Kharitonenkov A; Schuppan D; Flier JS; Maratos-Flier E
    Gastroenterology; 2014 Nov; 147(5):1073-83.e6. PubMed ID: 25083607
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thioredoxin-binding protein-2 deficiency enhances methionine-choline deficient diet-induced hepatic steatosis but inhibits steatohepatitis in mice.
    Ahsan MK; Okuyama H; Hoshino Y; Oka S; Masutani H; Yodoi J; Nakamura H
    Antioxid Redox Signal; 2009 Oct; 11(10):2573-84. PubMed ID: 19764881
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bardoxolone methyl prevents metabolic dysfunction-associated steatohepatitis by inhibiting macrophage infiltration.
    Onuma K; Watanabe K; Isayama K; Ogi S; Tokunaga Y; Mizukami Y
    Br J Pharmacol; 2024 Aug; 181(15):2545-2565. PubMed ID: 38599607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sphingomyelin synthase 2 loss suppresses steatosis but exacerbates fibrosis in the liver of mice fed with choline-deficient, L-amino acid-defined, high-fat diet.
    Sugimoto M; Hamada T; Wakabayasi M; Yoshioka T; Kato H; Konishi H; Nagai R; Suzuki M; Numata Y; Igarashi Y; Yukioka H
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1269-1275. PubMed ID: 33059919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.